Drug companies eye mRNA technology for flu shots

Drug companies eye mRNA technology for flu shots While Moderna, Pfizer and Sanofi have, in recent months, initiated Phase 1 trials of mRNA-based seasonal flu vaccine candidates, more companies intend to follow their leads next year. https://ift.tt/eA8V8J